These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 32879962)

  • 1. A Comprehensive Systematic Review of the Effects of Naringenin, a Citrus-Derived Flavonoid, on Risk Factors for Nonalcoholic Fatty Liver Disease.
    Naeini F; Namkhah Z; Ostadrahimi A; Tutunchi H; Hosseinzadeh-Attar MJ
    Adv Nutr; 2021 Mar; 12(2):413-428. PubMed ID: 32879962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Jazayeri-Tehrani SA; Yaseri M; Hosseinzadeh-Attar MJ
    Trials; 2021 Nov; 22(1):801. PubMed ID: 34774104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naringenin and its Nano-formulations for Fatty Liver: Cellular Modes of Action and Clinical Perspective.
    Zobeiri M; Belwal T; Parvizi F; Naseri R; Farzaei MH; Nabavi SF; Sureda A; Nabavi SM
    Curr Pharm Biotechnol; 2018; 19(3):196-205. PubMed ID: 29766801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic Effects and Mechanisms of Action of Garlic (
    Pourreza S; Azar PS; Sanaie S; Noshadi N; Jalali S; Niazkar HR; Karimi A; Vajdi M
    Evid Based Complement Alternat Med; 2022; 2022():6960211. PubMed ID: 37377647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin, a flavanone with antiviral and anti-inflammatory effects: A promising treatment strategy against COVID-19.
    Tutunchi H; Naeini F; Ostadrahimi A; Hosseinzadeh-Attar MJ
    Phytother Res; 2020 Dec; 34(12):3137-3147. PubMed ID: 32613637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Naringenin: A prospective therapeutic agent for Alzheimer's and Parkinson's disease.
    Goyal A; Verma A; Dubey N; Raghav J; Agrawal A
    J Food Biochem; 2022 Dec; 46(12):e14415. PubMed ID: 36106706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combating oxidative stress disorders with citrus flavonoid: Naringenin.
    Zaidun NH; Thent ZC; Latiff AA
    Life Sci; 2018 Sep; 208():111-122. PubMed ID: 30021118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naringenin supplementation on cardiovascular risk factors in overweight/obese patients with nonalcoholic fatty liver disease: a pilot double-blind, placebo-controlled, randomized clinical trial.
    Naeini F; Namkhah Z; Tutunchi H; Rezayat SM; Mansouri S; Yaseri M; Hosseinzadeh-Attar MJ
    Eur J Gastroenterol Hepatol; 2022 Mar; 34(3):345-353. PubMed ID: 34860705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic, pharmacodynamic and formulations aspects of Naringenin: An update.
    Joshi R; Kulkarni YA; Wairkar S
    Life Sci; 2018 Dec; 215():43-56. PubMed ID: 30391464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chinese herbal medicines: The modulator of nonalcoholic fatty liver disease targeting oxidative stress.
    Gong P; Long H; Guo Y; Wang Z; Yao W; Wang J; Yang W; Li N; Xie J; Chen F
    J Ethnopharmacol; 2024 Jan; 318(Pt B):116927. PubMed ID: 37532073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural Active Compounds from Plant Food and Chinese Herbal Medicine for Nonalcoholic Fatty Liver Disease.
    Liu Q; Zhu L; Cheng C; Hu YY; Feng Q
    Curr Pharm Des; 2017; 23(34):5136-5162. PubMed ID: 28925892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatoprotective and anti-inflammatory effects of total flavonoids of Qu Zhi Ke (peel of Citrus changshan-huyou) on non-alcoholic fatty liver disease in rats via modulation of NF-κB and MAPKs.
    Jiang J; Yan L; Shi Z; Wang L; Shan L; Efferth T
    Phytomedicine; 2019 Nov; 64():153082. PubMed ID: 31541796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of immunomodulatory properties of naringenin on the inhibition of inflammation and oxidative stress in autoimmune disease models: a systematic review and meta-analysis of preclinical evidence.
    Alimohammadi M; Mohammad RN; Rahimi A; Faramarzi F; Alizadeh-Navaei R; Rafiei A
    Inflamm Res; 2022 Nov; 71(10-11):1127-1142. PubMed ID: 35804246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological Properties and Therapeutic Potential of Naringenin: A Citrus Flavonoid of Pharmaceutical Promise.
    Rani N; Bharti S; Krishnamurthy B; Bhatia J; Sharma C; Kamal MA; Ojha S; Arya DS
    Curr Pharm Des; 2016; 22(28):4341-59. PubMed ID: 27238365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pure total flavonoids from citrus alleviate oxidative stress and inflammation in nonalcoholic fatty liver disease by regulating the miR-137-3p/NOXA2/NOX2 pathway.
    Yan JB; Nie YM; Xu SM; Zhang S; Chen ZY
    Phytomedicine; 2023 Sep; 118():154944. PubMed ID: 37393830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action.
    Alam MA; Subhan N; Rahman MM; Uddin SJ; Reza HM; Sarker SD
    Adv Nutr; 2014 Jul; 5(4):404-17. PubMed ID: 25022990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effects of citrus flavanones naringin and naringenin and their food sources on lipid metabolism: An update on bioavailability, pharmacokinetics, and mechanisms.
    Yang Y; Trevethan M; Wang S; Zhao L
    J Nutr Biochem; 2022 Jun; 104():108967. PubMed ID: 35189328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Potential Role of Naringin and Naringenin as Nutraceuticals Against Metabolic Syndrome.
    Massaro L; Raguzzini A; Aiello P; Valencia DV
    Endocr Metab Immune Disord Drug Targets; 2023; 23(4):428-445. PubMed ID: 36043734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of oleoylethanolamide, an endogenous PPAR-α agonist, on risk factors for NAFLD: A systematic review.
    Tutunchi H; Ostadrahimi A; Saghafi-Asl M; Maleki V
    Obes Rev; 2019 Jul; 20(7):1057-1069. PubMed ID: 31111657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.